C125P: Faricimab Biosimilar, Human ANGPT2/VEGFA Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade faricimab biosimilar specifically binds to the ANGPT2/VEGFA protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by faricimab.C117P: Emicizumab Biosimilar, Human F10, F9 Monoclonal Antibody
Recombinant Humanized IgG4 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade emicizumab biosimilar specifically binds to the F10, F9 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by emicizumab.C114P: Burosumab Biosimilar, Human FGF23 Monoclonal Antibody
Recombinant Humanized IgG1 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade burosumab biosimilar specifically binds to the FGF23 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by burosumab.C122P: Benralizumab Biosimilar, Human IL-5Ra Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade benralizumab biosimilar specifically binds to the IL-5 R alpha/CD125 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by benralizumab.C126P: Bedinvetmab Biosimilar, NGF/NGFB Monoclonal Antibody
Recombinant Caninized IgG2 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade bedinvetmab biosimilar specifically binds to the NGF/NGFB protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by bedinvetmab.C112P: Vandortuzumab Biosimilar, Anti-STEAP1 Monoclonal Antibody
Recombinant Humanized IgG1 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade vandortuzumab biosimilar specifically binds to the STEAP1 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by vandortuzumab.C111P: Risankizumab Biosimilar, Human IL-23A (p19) Monoclonal Antibody
Recombinant Humanized IgG1 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade risankizumab biosimilar specifically binds to the IL-23 alpha protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by risankizumab.C067P: Zalutumumab Biosimilar (Research Grade), Anti-human Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade zalutumumab biosimilar specifically binds to the human epidermal growth factor receptor (EGFR).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by zalutumumab.C066P: Toralizumab Biosimilar (Research Grade), Anti-human CD40L Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade toralizumab biosimilar specifically binds to the human CD40L / CD154 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by toralizumab.C064P: Satumomab Biosimilar (Research Grade), Anti-human TAG-72 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade satumomab biosimilar specifically binds to the human tumor-associated glycoprotein TAG-72.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by satumomab.